Amgen - PDFSEARCH.IO - Document Search Engine

Amgen
Results: 561

#	Item
251	Clinical Pharmacokinetics Review of BLA[removed]Enbrel, TNFR:Fc) Pharmacokinetic Studies Summary: . - Add to Reading List Source URL: www.fda.gov Language: English Immunosuppressants Cytokines Amgen Etanercept Bioequivalence Tumor necrosis factor-alpha Pharmacology Pharmaceutical sciences Pharmacokinetics
252	ENcourage Foundation® ENROLLMENT TIP SHEET FOR PROVIDERS ENcourage Foundation® may be able to help ENcourage Foundation® is a nonprofit patient assistance program supported by Amgen. If your patient qualifies for help Add to Reading List Source URL: www.encouragefoundation.com Language: English - Date: 2014-03-31 10:59:52 Pharmaceutical sciences Clinical pharmacology Medical prescription Pharmacology Medical ethics Health informatics Medicine Patient safety Health
253	Patient Label - Darbepoetin alfa (Aranesp), Amgen Incorporated Add to Reading List Source URL: www.fda.gov Language: English Medical equipment Biology Pharmacology Darbepoetin alfa Erythropoietin Syringe Amgen SureClick Medicine Erythropoiesis-stimulating agents Growth factors
254	PDF Document Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Biology Epoetin alfa Erythropoietin Amgen Biologic License Application Food and Drug Administration Biologic Medicine Erythropoiesis-stimulating agents Growth factors
255	Microsoft PowerPoint - Krzyzanski [Read-Only] [Compatibility Mode] Add to Reading List Source URL: www.accp1.org Language: English - Date: 2011-03-25 17:41:54 Growth factors Cytokines Amgen Hematology Granulocyte colony-stimulating factor Filgrastim Colony-stimulating factor Pegfilgrastim Bone marrow Biology Anatomy Cell biology
256	Understanding Causation in Private Securities Lawsuits: Building on Amgen Add to Reading List Source URL: securities.stanford.edu Language: English - Date: 2013-12-05 15:15:00 Investment Financial markets Basic Inc. v. Levinson Stock market SEC Rule 10b-5 Stoneridge Investment Partners v. Scientific-Atlanta Efficient-market hypothesis OTC Bulletin Board Futures contract Financial economics Finance United States securities law
257	Allos would like to request redaction addition of clarification in the FDA Briefing Document to the Oncologic Drugs Advisory Committee on NDA[removed]in the following sections: Add to Reading List Source URL: www.fda.gov Language: English Health Bone Medicine Pharmaceutical industry Amgen Denosumab Osteoporosis
258	Darbepoetin alfa, Aranesp, Patient Package Insert, Amgen Add to Reading List Source URL: www.fda.gov Language: English Growth factors Medical equipment Drug paraphernalia Darbepoetin alfa Erythropoietin Syringe Injection SureClick Medicine Pharmacology Erythropoiesis-stimulating agents
259	. DEPARTMENT OF HEALTH 8a HUMAN SERVICES Food and Drug Administration 1401 Rockviile Pike Add to Reading List Source URL: www.fda.gov Language: English Food and Drug Administration Immunosuppressants Amgen Etanercept Biologic Rheumatoid arthritis Center for Biologics Evaluation and Research Biotechnology Medicine Pharmacology
260	Responses to ENBREL in Part 1: Open label. Results of patients receiving open-label ENBREL for 3 months are summarized in Table 26. Last observation tied forward analysis is used, classifying dropouts as non-responders. Add to Reading List Source URL: www.fda.gov Language: English* Immunosuppressants Clinical research Pharmacology Amgen Etanercept Placebo Clinical trial Methadone Anakinra Medicine Health Chemistry